{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:06:25Z","timestamp":1791331585048,"version":"4.3.1"},"reference-count":42,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T00:00:00Z","timestamp":1334707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Follicular lymphoma (<jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>) comprises nearly 25% of non\u2010<jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>odgkin lymphoma cases and is clinically characterized by initial sensitivity to chemotherapy followed by relapse. <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> stroma contains a special type of stromal cell found in the germinal centre of lymph nodes\u2014the follicular dendritic cell (<jats:styled-content style=\"fixed-case\">FDC<\/jats:styled-content>). We first isolated tumourigenic cells from the <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> cell line <jats:styled-content style=\"fixed-case\">FLK<\/jats:styled-content>\u20101 by side population (<jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>) technique, and found that <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content> cells, which express <jats:styled-content style=\"fixed-case\">ABCG<\/jats:styled-content>2, were enriched by chemotherapy and radiation treatments. <jats:italic>In vitro<\/jats:italic>,<jats:styled-content style=\"fixed-case\"> SP<\/jats:styled-content> cells were attracted by and adhered to <jats:styled-content style=\"fixed-case\">FDC<\/jats:styled-content>s through chemokine (<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">X<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content> motif) ligand 12\/chemokine (<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">X<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content> motif) receptor 4 (<jats:styled-content style=\"fixed-case\">CXCL<\/jats:styled-content>12\/<jats:styled-content style=\"fixed-case\">CXCR<\/jats:styled-content>4) signalling. <jats:italic>In vivo<\/jats:italic>, limiting dilution assays showed <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content> cells were highly enriched in cancer stem cells (<jats:styled-content style=\"fixed-case\">CSC<\/jats:styled-content>), but required <jats:styled-content style=\"fixed-case\">FDC<\/jats:styled-content> for tumour formation in non\u2010obese diabetic\/severe combined immunodeficiency mice. Treatment with <jats:styled-content style=\"fixed-case\">AMD<\/jats:styled-content>3100, a specific <jats:styled-content style=\"fixed-case\">CXCL<\/jats:styled-content>12\/<jats:styled-content style=\"fixed-case\">CXCR<\/jats:styled-content>4 inhibitor, eliminated tumour growth. These findings were then verified with <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> cells isolated from an <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> patient's ascitic fluid (<jats:styled-content style=\"fixed-case\">FLA<\/jats:styled-content>\u20101). Finally, we detected the <jats:styled-content style=\"fixed-case\">ABCG<\/jats:styled-content>2 expressing lymphoma cells in <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> clinical specimens. Thus, we found that the highly tumourigenic <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> cells having <jats:styled-content style=\"fixed-case\">CSC<\/jats:styled-content>\u2010like activities (<jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">SC<\/jats:styled-content>) interact with <jats:styled-content style=\"fixed-case\">FDC<\/jats:styled-content>s in a <jats:styled-content style=\"fixed-case\">CXCL<\/jats:styled-content>12\/<jats:styled-content style=\"fixed-case\">CXCR<\/jats:styled-content>4 dependent manner to resist chemotherapy. Our results indicate the importance of <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">SC<\/jats:styled-content> and niche cell signalling in maintaining tumourigenicity. These signals represent novel targets for <jats:styled-content style=\"fixed-case\">CSC<\/jats:styled-content> eradication.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2012.09123.x","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T08:58:48Z","timestamp":1334739528000},"page":"79-90","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["A rare fraction of drug\u2010resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential"],"prefix":"10.1111","volume":"158","author":[{"given":"Chung\u2010Gi","family":"Lee","sequence":"first","affiliation":[{"name":"Laboratory of Cellular Immunology Ochsner Clinic Foundation New Orleans LA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikul","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Stanford University Medical School Stanford CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara L.","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology University of Kansas Kansas City KS USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Grimes","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Immunology Ochsner Clinic Foundation New Orleans LA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Immunology Ochsner Clinic Foundation New Orleans LA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Lavezzi","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Immunology Ochsner Clinic Foundation New Orleans LA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology Ochsner Clinic Foundation New Orleans LA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cole","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Ochsner Clinic Foundation New Orleans LA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Yau","sequence":"additional","affiliation":[{"name":"Department of Biostatistics Tulane University New Orleans LA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Immunology Ochsner Clinic Foundation New Orleans LA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,4,18]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2000.90147.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2780"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2009.01414.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0797-730"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3182"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-225326"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2007-0724"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190903093815"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-202465"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2246"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2007.06.002"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3557"},{"issue":"1","key":"e_1_2_7_14_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/annonc\/11.suppl_1.S23","article-title":"Follicular lymphoma: have we made any progress?","volume":"11","author":"Horning S.J.","year":"2000","journal-title":"Annals of Oncology"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2009.06.008"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.8428"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-267344"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-11-189688"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402002"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-11-189308"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.3.1101"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1998.tb01447.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4142"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-024687"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802885"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1044-5323(02)00058-1"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.6.1077"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0292"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1593\/neo.11324"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-347518"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-021113"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/35102167"},{"key":"e_1_2_7_33_1","first-page":"729","article-title":"Cancer stem cell characteristics in retinoblastoma","volume":"11","author":"Seigel G.M.","year":"2005","journal-title":"Mol Vis"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.195"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2008.07.013"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1309\/EG2M-YHB9-WEFW-7H1R"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00865.x"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2499"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4343"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5457.1427"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.03.048"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7254.2006.00415.x"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.12.015"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2012.09123.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2012.09123.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T05:02:12Z","timestamp":1700542932000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2012.09123.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,18]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1111\/j.1365-2141.2012.09123.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09123.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,18]]},"assertion":[{"value":"2012-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-03-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-04-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}